Lipid-lowering therapy--benefits and risks.
Abinader
E G
EG
D000369:Aged, 80 and over; D001384:Azetidines / Q000009:adverse effects*; D003327:Coronary Disease / Q000517:prevention & control; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006937:Hypercholesterolemia / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D009135:Muscular Diseases / Q000139:chemically induced*; D012307:Risk Factors
D001384:Azetidines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D000069438:Ezetimibe